Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA
Matthias Tenbusch(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ulrike Protzer(German Center for Infection Research), Ronja Brockhoff(University of Cologne), Emanuel Vogel(Helmholtz Munich), Hrvoje Mijočević(Technical University of Munich), Sarah Yazici(TUM Klinikum), Sofie Schumacher(University of Cologne), Philipp Steininger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Pascal Irrgang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alina Priller(TUM Klinikum), Jürgen Held(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jon Salmanton‐García(University Hospital Cologne), Kathrin Tinnefeld(Helmholtz Munich), Oliver A. Cornely(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Percy A. Knolle(TUM Klinikum), Christian Bogdan(Friedrich-Alexander-Universität Erlangen-Nürnberg), Klaus Überla(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stephanie Beileke(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 5
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|922